Regulatory concerns include debates about gender identity, the role of governments in health care, and the medical management of minors. Some countries restrict the use of puberty blockers, whereas others consider the drugs essential for transgender youth. The United Kingdom banned the use of puberty blockers in 2024, owing to a lack of evidence on benefits and harms.
verifiedCite
While every effort has been made to follow citation style rules, there may be some discrepancies.
Please refer to the appropriate style manual or other sources if you have any questions.
Select Citation Style